Sangamo shares fell on Pfizer’s decision to hand back rights to a hemophilia gene therapy. Elsewhere, Novartis got ...
The biotechnology sector once again starts a new year on shaky footing. Acquisitions of publicly traded biotech companies ...
Dec. 31, 2024 – Jan. 22, 2025 • New York, New York ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback